Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Walsh

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cell|November 2, 2025
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Induction of multiple HIV-1 neutralizing B Cell Precursors in HumansChen-Hao Yeh, Stephen R Walsh, Ruth Parsons, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Nature Communications|February 5, 2024
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|May 15, 2021
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|April 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cell|November 2, 2025
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Cell|May 18, 2024
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humansWilton B Williams, S Munir Alam, Gilad Ofek, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Induction of multiple HIV-1 neutralizing B Cell Precursors in HumansChen-Hao Yeh, Stephen R Walsh, Ruth Parsons, et al.
Science Translational Medicine|July 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trialK Rachael Parks, Zoe Moodie, Mary A Allen, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Nature Communications|February 5, 2024
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|May 15, 2021
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Nature Communications|April 16, 2021
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Andreas M Schmitt, Perrine Janiaud, et al.
Pageof 8